Having worked on more than 80 projects across the US, Europe, Asia and South America, Dolan has experience in market and product assessment, portfolio assessment, brand planning, business development, and development of global franchise and brand strategies. He has also participated and led strategic reorganizations for marketing functions at global pharmaceutical companies, enhancing commercialization effectiveness for the development of in-line assets.Dolan holds a PhD in Microbiology and Immunology from Northwestern University Feinberg School of Medicine. A full profile of Dolan appears in the March 2014 issue of Consulting Magazine. About Navigant Navigant (NYSE: NCI) is a specialized, global expert services Firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Through senior level engagement with clients, Navigant professionals combine technical expertise in Disputes and Investigations, Economics, Financial Advisory and Management Consulting, with business pragmatism in the highly regulated Construction, Energy, Financial Services and Healthcare industries to support clients in addressing their most critical business needs. More information about Navigant can be found at www.navigant.com.
Today, Navigant announced that James Dolan, PhD, Associate Director on the Firm’s Life Sciences Strategy team, appears on Consulting Magazine’s list of " Rising Stars of the Profession," which recognizes outstanding talent under the age of 35. Dolan was selected because of his vast contributions to the Life Sciences division within Navigant’s Healthcare practice and for his passion for driving innovation throughout the Firm and on behalf of clients. “We’re thrilled to see James on the list of Rising Stars in the industry,” stated Eduardo Schur, Managing Director in the Healthcare practice and global leader of Navigant’s Life Sciences Strategy team. “The recognition by Consulting Magazine affirms what we have long believed about James’ significant contributions – he provides strategic thinking rooted in deep clinical expertise to his clients, adding a spark of innovation and perspective that is incredibly valuable.” Dolan was among the more than 200 nominees considered by Consulting Magazine. During his five year tenure with Navigant, Dolan has provided consulting services in the areas of immunology and autoimmune disease, oncology, cardiovascular disease, neuroscience, respiratory disease and diabetes. In addition to his consulting work, Dolan is a strategic advisor to the Firm’s Innovation Development Council, providing best practice insight and programmatic direction in support of ideation to drive Firm growth and broaden the Firm’s portfolio. “It is both humbling and inspiring to be recognized with this award at such an early stage of my career,” said Dolan. “I am further energized by the recognition of my leadership that I’ve earned from practice and executive management. I’m excited to being a part of a growing Life Sciences business and the growth trajectory that Navigant is on, and I am looking forward to continuing to realize success on behalf of my clients and the Firm for a long time ahead.”